PubRank
Search
About
Shuta Tomida
Author PubWeight™ 62.39
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
Cancer Res
2004
18.86
2
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
Cancer Res
2005
10.46
3
Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
Cancer Sci
2005
4.55
4
Propionibacterium acnes strain populations in the human skin microbiome associated with acne.
J Invest Dermatol
2013
3.32
5
Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.
Cancer Res
2007
2.59
6
Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.
J Clin Oncol
2006
2.37
7
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.
J Clin Oncol
2004
1.89
8
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma.
Cancer Cell
2012
1.68
9
An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains.
PLoS One
2012
1.34
10
Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.
Cancer Res
2008
1.30
11
A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
J Natl Cancer Inst
2007
1.30
12
MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis.
EMBO J
2011
1.17
13
miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.
Cancer Res
2011
1.10
14
Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma.
BMC Bioinformatics
2004
1.03
15
Analysis of complete genomes of Propionibacterium acnes reveals a novel plasmid and increased pseudogenes in an acne associated strain.
Biomed Res Int
2013
0.98
16
Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses.
Cancer Res
2009
0.94
17
Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions.
Oncotarget
2014
0.92
18
Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas.
Mol Carcinog
2011
0.91
19
Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.
Cancer Res
2010
0.88
20
PCNA mono-ubiquitination and activation of translesion DNA polymerases by DNA polymerase {alpha}.
J Biochem
2009
0.85
21
The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin.
ISME J
2015
0.81
22
Inhibition of β-Catenin enhances the anticancer effect of irreversible EGFR-TKI in EGFR-mutated non-small-cell lung cancer with a T790M mutation.
J Thorac Oncol
2015
0.81
23
Inference of common genetic network using fuzzy adaptive resonance theory associated matrix method.
J Biosci Bioeng
2003
0.81
24
Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica.
BMC Microbiol
2012
0.80
25
Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer.
Mol Cancer
2014
0.80
26
Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis.
Int J Proteomics
2012
0.79
27
Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways.
Cancer Res
2010
0.79
28
DIAMETER is a KEY 3D CHARACTERISTIC for ASSESSMENTS of EFFICIENT INHIBITORS of PROTEIN-PROTEIN INTERACTIONS.
J Chem Inf Model
2020
0.75